§ 01 Overview
Overview
Compounded extension of GLOW that adds KPV to BPC-157, TB-500, and GHK-Cu for broad repair and anti-inflammatory effects.
No controlled data on the blend.
§ 02 Mechanism
Mechanism of action
KLOW adds KPV's NF-κB inhibition to the GLOW blend, providing an additional anti-inflammatory layer alongside the repair and collagen signaling of the base components.
- 01Broad systemic repair plus anti-inflammatory tone
- 02Convenience of single-vial stacking
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- 12 – 16 units daily
- Route
- SubQ
- Frequency
- Daily
- Cycle
- 6–8 weeks
§ 04 Evidence
Evidence & research
No controlled data on the blend.
FDA Status
Not FDA-approved.
§ 05 Stacks
Common stacks
§ 06 News
In the news
8 articles from the last 12 months · updates hourly
KLOW vs GLOW Peptide Blends: A Research Comparison - OCNJ Daily
KLOW vs GLOW Peptide Blends: A Research Comparison OCNJ Daily
The US is hooked on unregulated peptides. But are they effective, or even safe? - Live Science
The US is hooked on unregulated peptides. But are they effective, or even safe? Live Science
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg - GlobeNewswire
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg GlobeNewswire
ipamorelin benefits risks side effects Radiance Recovery Blend (KLOW Blend): Heal, Restore, and Renew from Within - Financial Issues Stewardship Ministries
ipamorelin benefits risks side effects Radiance Recovery Blend (KLOW Blend): Heal, Restore, and Renew from Within Financial Issues Stewardship Ministries
Your clinical guide: Managing patients using 'peptide stacks' for chronic pain and anti-aging - MDLinx
Your clinical guide: Managing patients using 'peptide stacks' for chronic pain and anti-aging MDLinx
The Growing Market for Research Peptides: Opportunities and Risks - bioinformant.com
The Growing Market for Research Peptides: Opportunities and Risks bioinformant.com
What to Know About the ‘Anti-Aging’ Peptide Shots Flooding Social Media - Time Magazine
What to Know About the ‘Anti-Aging’ Peptide Shots Flooding Social Media Time Magazine
Harnessing Synergy: How Multi-Peptide Blends Are Revolutionizing Wellness - Vocal
Harnessing Synergy: How Multi-Peptide Blends Are Revolutionizing Wellness Vocal
§ 07 Sourcing
Sourcing & supply
Regulatory status
Restricted from compounding
Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales.
Research-use-only · 1
Ascension Peptides
Among newer RUO vendors with cleaner credibility signals. SafeCert Labs (CLIA-certified) testing, 4.8 Trustpilot. US-only.
Listings are informational, not endorsement. Verify credentials and flags against FDA and PCAB databases before purchasing. Full directory & how to verify →
§ 09 Safety
Safety & side effects
Side effects
- 01As per components
Contraindications
None specified.
§ 10 Questions
KLOW FAQ
- What is KLOW?
- Compounded extension of GLOW that adds KPV to BPC-157, TB-500, and GHK-Cu for broad repair and anti-inflammatory effects. KLOW adds KPV's NF-κB inhibition to the GLOW blend, providing an additional anti-inflammatory layer alongside the repair and collagen signaling of the base components.
- What is KLOW used for?
- Reported uses include broad systemic repair plus anti-inflammatory tone and convenience of single-vial stacking. Evidence strength is rated Experimental — see the evidence section for detail.
- How is KLOW dosed?
- Commonly referenced dosing is 12 – 16 units daily, administered SubQ. This is educational reference only; consult a licensed clinician before use.
- What are the side effects of KLOW?
- Commonly reported side effects include as per components. This list is not exhaustive.
- Is KLOW legal?
- Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales. FDA status: Not FDA-approved..